Playback speed
10 seconds
2019 SOHO Updates on CML: Frontline Therapy is Good, Getting Better and Safer, 2nd Line Options Grossly Equivalent, 3rd Line Ponatinib is Better, Complete Cytogenetic Response Improves Survival
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Elias Jabbour
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Elias Jabbour
145 views
December 13, 2019
Login to view comments.
Click here to Login